Literature DB >> 31800966

Secondary hyperparathyroidism: recurrence after total parathyroidectomy with autotransplantation.

Lukas Steffen1, Giusi Moffa2, Philip C Müller3, Daniel Oertli4.   

Abstract

BACKGROUND: Secondary hyperparathyroidism (sHPTH) is common in patients with end-stage chronic kidney disease. If drug therapy fails, total parathyroidectomy with autotransplantation of parathyroid tissue into the forearm (PTX-AT) is the most widely used procedure. High recurrence rates of sHPTH following PTX-AT are reported in the literature.
OBJECTIVE: The aim of this study was to evaluate recurrences of sHPTH following PTX-AT in detail in order to develop strategies to prevent recurrences in the future.
METHODS: This retrospective study analysed a single-centre cohort of 42 patients who underwent PTX-AT for sHPTH at a tertiary centre in Switzerland. Postoperative PTH levels were evaluated to determine the recurrence and persistence rates and the time to recurrence. Furthermore, the peri- and postoperative outcomes were assessed. Patients on dialysis and patients with a functioning kidney transplant suffering tertiary HPTH were analysed separately.
RESULTS: Intraoperative measurements showed that serum PTH decreased to 6.9% (3.3–15.0%) of the preoperative baseline level. After a median follow-up of 89.5 months (IQR 31.9–152.9), persistence of sHPTH was found in five patients (11.9%) and recurrence in four patients (9.5%), giving a total recurrence rate of 21.4%.
CONCLUSION: Recurrence of sHPTH after PTX remains a problem, occurring in every fifth patient. In our experience, the introduction of intraoperative PTH measurement has helped to lower the rates of persistence and recurrence. Further reductions in the recurrence rate might be achieved with novel, more accurate pre- and intraoperative imaging techniques.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31800966     DOI: 10.4414/smw.2019.20160

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  3 in total

1.  Impact of dexmedetomidine on secondary hyperparathyroidism recurrence in uremic patients who received parathyroidectomy with auto-transplantation: a retrospective propensity-matched study.

Authors:  Yun Wu; Wei Han; Peikun Li; Xianwen Hu; Ye Zhang
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

2.  Minimally invasive video-assisted parathyroidectomy (MIVAP) versus conventional parathyroidectomy for renal hyperparathyroidism: a retrospective multicenter study.

Authors:  Iurii Snopok; Richard Viebahn; Martin Walz; Panagiota Zgoura; Pier Francesco Alesina
Journal:  Updates Surg       Date:  2022-05-25

3.  Robotic resection of ectopic mediastinal parathyroid adenoma with intraoperative parathyroid hormone monitoring: a case report.

Authors:  Yoshihito Iijima; Masahito Ishikawa; Shun Iwai; Aika Yamagata; Kazuhiro Kishimoto; Nozomu Motono; Hidetaka Uramoto
Journal:  J Cardiothorac Surg       Date:  2022-08-20       Impact factor: 1.522

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.